Suppr超能文献

仅前列腺放疗时盆腔淋巴结区域的偶然剂量。

Incidental Dose to Pelvic Nodal Regions in Prostate-Only Radiotherapy.

作者信息

Murthy Vedang, Lewis Shirley, Sawant Mayur, Paul Siji N, Mahantshetty Umesh, Shrivastava Shyam Kishore

机构信息

1 Department of Radiation Oncology, Tata Memorial Centre, Mumbai, India.

2 Department of Medical Physics, Tata Memorial Centre, Mumbai, India.

出版信息

Technol Cancer Res Treat. 2017 Apr;16(2):211-217. doi: 10.1177/1533034616661447. Epub 2016 Aug 19.

Abstract

OBJECTIVES

Pelvic lymph nodal regions receive an incidental dose from conformal treatment of the prostate. This study was conducted to investigate the doses received by the different pelvic nodal regions with varying techniques used for prostate radiotherapy.

METHODS AND MATERIALS

Twenty patients of high-risk node-negative prostate cancer treated with intensity-modulated radiotherapy to the prostate alone were studied. Replanning was done for intensity-modulated radiotherapy, 3-dimensional conformal treatment, and 2-dimensional conventional radiotherapy with additional delineation of the pelvic nodal regions, namely, common iliac (upper and lower), presacral, internal iliac, obturator, and external iliac. Dose-volume parameters such as Dmean, D100%, D66%, D33%, V40, and V50 to each of the nodal regions were estimated for all patients.

RESULTS

The obturator nodes received the highest dose among all nodal regions. The mean dose received by obturator nodal region was 44, 29, and 22 Gy from 2-dimensional conventional radiotherapy, 3-dimensional conformal treatment, and intensity-modulated radiotherapy, respectively. The mean dose was significantly higher when compared between 2-dimensional conventional radiotherapy and 3-dimensional conformal treatment ( P < .001), 2-dimensional conventional radiotherapy and intensity-modulated radiotherapy ( P < .001), and 3-dimensional conformal treatment and intensity-modulated radiotherapy ( P < .001). The D33% of the obturator region was 64, 39, and 37 Gy from 2-dimensional conventional radiotherapy, 3-dimensional conformal treatment, and intensity-modulated radiotherapy, respectively. The dose received by all other pelvic nodal regions was low and not clinically relevant.

CONCLUSION

The incidental dose received by obturator regions is significant especially with 2-dimensional conventional radiotherapy and 3-dimensional conformal treatment techniques as used in the trials studying elective pelvic nodal irradiation. However, with intensity-modulated radiotherapy, this dose is lower, making elective pelvic irradiation more relevant. Advances in Knowledge: This study highlights that incidental dose received by obturator regions is significant especially with 2-dimensional conventional radiotherapy and 3-dimensional conformal treatment techniques.

摘要

目的

盆腔淋巴结区域在前列腺适形治疗中会受到附带剂量。本研究旨在调查采用不同技术进行前列腺放疗时,不同盆腔淋巴结区域所接受的剂量。

方法与材料

对20例仅接受前列腺调强放疗的高危淋巴结阴性前列腺癌患者进行研究。针对调强放疗、三维适形治疗和二维常规放疗进行重新计划,并额外勾画出盆腔淋巴结区域,即髂总(上、下)、骶前、髂内、闭孔和髂外淋巴结区域。估算所有患者各淋巴结区域的剂量体积参数,如平均剂量(Dmean)、D100%、D66%、D33%、V40和V50。

结果

闭孔淋巴结在所有淋巴结区域中接受的剂量最高。二维常规放疗、三维适形治疗和调强放疗时,闭孔淋巴结区域接受的平均剂量分别为44 Gy、29 Gy和22 Gy。二维常规放疗与三维适形治疗之间(P < .001)、二维常规放疗与调强放疗之间(P < .001)以及三维适形治疗与调强放疗之间(P < .001)比较,平均剂量均有显著差异。二维常规放疗、三维适形治疗和调强放疗时,闭孔区域的D33%分别为64 Gy、39 Gy和37 Gy。其他所有盆腔淋巴结区域接受的剂量较低,无临床意义。

结论

闭孔区域接受的附带剂量显著,尤其是在研究选择性盆腔淋巴结照射的试验中所采用的二维常规放疗和三维适形治疗技术时。然而,采用调强放疗时,该剂量较低,使选择性盆腔照射更具相关性。知识进展:本研究强调闭孔区域接受的附带剂量显著,尤其是在二维常规放疗和三维适形治疗技术时。

相似文献

1
Incidental Dose to Pelvic Nodal Regions in Prostate-Only Radiotherapy.
Technol Cancer Res Treat. 2017 Apr;16(2):211-217. doi: 10.1177/1533034616661447. Epub 2016 Aug 19.
2
Incidental Dose to Pelvic Nodes in Bladder-Only Radiotherapy: Is It Clinically Relevant?
Technol Cancer Res Treat. 2017 Jun;16(3):382-387. doi: 10.1177/1533034617691409. Epub 2017 Feb 7.
6
Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer.
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):994-1002. doi: 10.1016/j.ijrobp.2009.01.044. Epub 2009 Jul 18.
8
A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):898-902. doi: 10.1016/j.ijrobp.2007.02.030. Epub 2007 Apr 24.

引用本文的文献

本文引用的文献

1
Molecularly targeted agents as radiosensitizers in cancer therapy--focus on prostate cancer.
Int J Mol Sci. 2013 Jul 16;14(7):14800-32. doi: 10.3390/ijms140714800.
3
Mapping of pelvic lymph node metastases in prostate cancer.
Eur Urol. 2013 Mar;63(3):450-8. doi: 10.1016/j.eururo.2012.06.057. Epub 2012 Jul 6.
4
Effect of whole pelvic radiotherapy for patients with locally advanced prostate cancer treated with radiotherapy and long-term androgen deprivation therapy.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e721-6. doi: 10.1016/j.ijrobp.2010.12.003. Epub 2011 Jan 27.
7
Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):329-36. doi: 10.1016/j.ijrobp.2009.04.075. Epub 2009 Sep 24.
9
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):377-82. doi: 10.1016/j.ijrobp.2008.08.003. Epub 2008 Oct 22.
10
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):383-7. doi: 10.1016/j.ijrobp.2008.08.002. Epub 2008 Oct 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验